CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $2,161,962
- in 6 filings, $2.2M under 10b5-1 plans
Net −$1,277,210. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-28 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,344 | $0.46 | $618 | 183,650 |
| 2023-07-27 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,373 | $0.53 | $728 | 184,994 |
| 2023-07-26 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,329 | $0.51 | $678 | 186,367 |
| 2023-07-25 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,390 | $0.50 | $695 | 187,696 |
| 2023-07-24 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,438 | $0.54 | $777 | 189,086 |
| 2023-07-21 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,333 | $0.61 | $813 | 190,524 |
| 2023-07-20 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,361 | $0.64 | $871 | 191,857 |
| 2023-07-19 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,335 | $0.65 | $868 | 193,218 |
| 2023-07-18 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,484 | $0.56 | $831 | 194,553 |
| 2023-07-17 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,415 | $0.67 | $948 | 196,037 |
| 2023-07-14 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −906 | $0.59 | $535 | 197,452 |
| 2023-07-13 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,329 | $0.39 | $518 | 198,358 |
| 2023-07-12 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,335 | $0.39 | $521 | 199,687 |
| 2023-07-11 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,363 | $0.37 | $504 | 201,022 |
| 2023-07-10 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,304 | $0.37 | $482 | 202,385 |
| 2023-07-10 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,304 | $0.37 | $482 | 66,023 |
| 2023-07-10 | Loose Christopher R. Chief Scientific Officer | Option exercise 10b5-1 | +4,546 | 70,569 | ||
| 2023-07-10 | Loose Christopher R. Chief Scientific Officer | Option exercise · Restricted Stock Unit 10b5-1 | −4,546 | 131,816 | ||
| 2023-07-07 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,306 | $0.36 | $470 | 203,689 |
| 2023-07-07 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,306 | $0.36 | $470 | 62,781 |
Page 1 of 3 · 48 trades